Allergan plc Ordinary Shares (AGN) Real-Time Stock Quote ... AGN's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low AGN Price Target - ETF Channel The median AGN price target (a different metric than the average or mean) was $188.0 as of 2020-03-23, the highest AGN price target in the range was $255.0 while the lowest AGN price target in the range was $133.0, with a standard deviation of $35.024. Get the latest Zacks research report on AGN — FREE. 10 ETFs With Most Upside To Analyst Targets ALLERGAN PLC : Target Price Consensus and Analysts ...
Allergan Plc - NYSE:AGN - Stock Quote & News - TheStreet View detailed financial information, real-time news, videos, quotes and analysis on Allergan Plc (NYSE:AGN). Explore commentary on Allergan Plc and hear what the experts at TheStreet are saying
AGN Stock Price, Financials & News | Stock Target Advisor Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios. Allergan plc [AGN]: Target Price for AGN is $183.40 as ...
Allergan plc Stock Quote: AGN Stock News, Quotes, Analysis ... Nov 08, 2019 · AGN, Allergan plc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines AGN Stock Quote of Allergan Plc Feb 10, 2020 · Investors in Allergan PLC (AGN) saw new options begin trading today, for the May 8th expiration. At Stock Options Channel, our YieldBoost formula has … Allergan Price Target | AGN View Price Target for AGN Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
AGN | Allergan PLC Analyst Estimates | MarketWatch